Altria Group, Inc.

Altria Group, Inc.

CIK 764180 · View on SEC EDGAR ↗

Activist

First SEC filing: Feb. 7, 2025 · Latest: Feb. 7, 2025

On this page

Altria Group, Inc. is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes, and medical products in the treatment of illnesses caused by tobacco. It operates worldwide and is headquartered in the city of Richmond, Virginia.

Read more

Altria Group, Inc. is an American corporation and one of the world's largest producers and marketers of tobacco, cigarettes, and medical products in the treatment of illnesses caused by tobacco. It operates worldwide and is headquartered in the city of Richmond, Virginia.

Altria is the parent company of Philip Morris USA, John Middleton, Inc., U.S. Smokeless Tobacco Company, Inc., Philip Morris Capital Corporation, and NJOY Holdings, Inc. Altria also maintains large minority stakes in Belgium-based brewer AB InBev and the Canadian cannabis company Cronos Group. It is a component of the S&P 500 and was a component of the Dow Jones Industrial Average from 1985 to 2008, dropping due to spin-offs of Kraft Foods Inc. in 2007 and Philip Morris International in 2008.

A study published in Science Advances in 2024 found that Altria was responsible for 2% of global branded plastic pollution (by count), which was the 5th highest share of branded plastic pollution globally.

History

Altria emerged from Philip Morris USA. The onset of "rebranding" of Philip Morris Companies to Altria took place in 2003 (Philip Morris would later split, with Philip Morris USA remaining Altria's primary and only consistently held asset). According to Altria, it was created because Philip Morris wished to emphasize that its business portfolio had come to consist of more than Philip Morris USA and Philip Morris International; at the time, it owned an 84% stake in Kraft Foods, although that business has since been spun off. The name "Altria" is claimed to come from the Latin word for "high" and was part of a trend of companies rebranding to names that previously did not exist, Accenture (previously Andersen Consulting) and Verizon being notable examples, though linguist Steven Pinker suggests that in fact the name is an "egregious example" of phonesthesia—with the company attempting to "switch its image from bad people who sell addictive carcinogens to a place or state marked by altruism and other lofty values".

The company's branding consultants, the Wirthlin Group, said: "The name change alternative offers the possibility of masking the negatives associated with the tobacco business", thus enabling the company to improve its image and raise its profile without sacrificing tobacco profits. Philip Morris executives thought a name change would insulate the larger corporation and its other operating companies from the political pressures on tobacco.

The rebranding took place amidst social, legal, and financially troubled circumstances. In 2003 Altria was ranked Fortune number 11, and has steadily declined since. In 2010 Altria Group (MO) ranked at Fortune number 137, whereas its former asset, Philip Morris International, was ranked 94th.

In 2006, a United States court found that Philip Morris "publicly ... disputed scientific findings linking smoking and disease knowing their assertions were false." In a 2006 ruling, a federal court found that Altria, along with R. J. Reynolds, Lorillard and Philip Morris were found guilty of misleading the public about the dangers of smoking. Within this ruling, it was noted that "defendants altered the chemical form of nicotine delivered in mainstream cigarette smoke for the purpose of improving nicotine transfer efficiency and increasing the speed with which nicotine is absorbed by smokers." This was done by manipulating smoke pH with ammonia. Adding ammonia increases the smoke pH, in a process called "freebasing" which causes smokers to be "exposed to higher internal nicotine doses and become more addicted to the product."

On March 30, 2007, Altria's 88.1% stake in Kraft Foods was spun off, through a distribution of the remaining stake of shares (88.1%) to Altria shareholders. That same year, Altria began selling all its shares of Philip Morris International to Altria stockholders, a spin-off that was completed on March 28, 2008. Again in 2007 the company began the acquisition of cigar manufacturer John Middleton Co. from Bradford Holdings, which was complete in 2008. After Philip Morris International spun off, the former international subsidiaries halted the purchase of tobacco from America, which was a major factor in the closing of a newly renovated plant in North Carolina, an approximately 50% reduction in manufacturing, large-scale layoffs, and induced early retirements.

In 2008, Altria officially moved its headquarters from New York City to Richmond, Virginia, after Philip Morris sold its downtown offices in New York City a decade earlier. With a few exceptions, all manufacturing, commercial, and executive employees had long been based in and around Richmond. The company is now headquartered in an unincorporated area within Henrico County, less than five miles (8.0 km) west of the city limits of Richmond and less than 10 miles (16 km) from its downtown Richmond campus.

Aside from the Philip Morris/Altria headquarters, some of their other buildings included the Altria Center for Research and Technology in downtown Richmond, their manufacturing center in South Richmond, and the adjacent operations center which began shutting down in 2007–2008, as a result of the loss of demand from Philip Morris International member companies. The layoffs beginning in 2007 affected thousands of Altria, Altria Client Services, Philip Morris USA, and contracted employees in Richmond and North Carolina.

In 2009, Altria finalized its purchase of UST Inc., whose products included smokeless tobacco (made by U.S. Smokeless Tobacco Company) and wine (made by Chateau Ste. Michelle). This ended a short era of competition between the new Marlboro smokeless tobacco products such as snus, and those produced by UST Inc.

On December 8, 2018, Altria announced its intent to acquire a 45% stake in Cronos Group for $1.8 billion.

On December 20, 2018, Altria finalized the acquisition of a 35% stake in JUUL Labs, an e-cigarette company based out of San Francisco, California, for $12.8 billion. On November 3, 2019, it was reported that Altria was taking a $4.5 billion writedown on its stake in Juul, 35% of its original value. On July 28, 2022, it was reported that Altria's investment in Juul is now worth only 5% of the original amount of $12.8 billion. Despite the losses, Altria has announced that it will continue to support Juul and avoid investing in competing products.

Altria is taking a stake in the global business of Swiss tobacco company Burger Söhne (Helix Innovations with the On! brand) for $372 million in June 2019.

Altria and Japan Tobacco announced a joint venture called Horizon Innovations LLC on October 27, 2022. Horizon, owned 75 percent by Altria and 25 percent by Japan Tobacco, intends to sell Ploom heated tobacco sticks in the United States. FDA approval was expected to take until 2025, with customers able to buy Ploom by 2027.

Altria completed the acquisition of NJOY Holdings, Inc. on June 1, 2023.

Finances

For the fiscal year 2020, Altria reported earnings of US$4.45 billion, with an annual revenue of US$26.15 billion. Altria's shares traded at over $66 per share, and its market capitalization was valued at over US$118.5 billion in October 2018. As of 2018, the company ranked 154th on the Fortune 500 list of the largest United States corporations by revenue.

Corporate governance

Board of directors

Members of the board of directors of Altria Group as of February 2013 were:

Elizabeth E. Bailey, professor emerita, the Wharton School, University of Pennsylvania

Gerald L. Baliles (2008–2019), director, Miller Center of Public Affairs at University of Virginia; former Virginia governor

Martin Barrington, chairman and chief executive officer, Altria Group, Inc.

John T. Casteen III (2010– ), president emeritus, University of Virginia

Dinyar S. Devitre (2008– ), special advisor, General Atlantic Partners, New York, NY; former SVP and CFO of Altria

Thomas F. Farrell II (2008–2021), chairman, president and CEO, Dominion Resources, Richmond, VA

Thomas W. Jones (2002– ), senior partner, TWJ Capital LLC, Stamford, CT; formerly with Citigroup, Travelers and TIAA-CREF

Debra J. Kelly-Ennis (2013– ), former president and CEO of Diageo Canada, Inc.; also formerly with RJR Nabisco, Inc., Coca-Cola, General Motors and Grand Metropolitan

W. Leo Kiely III (2011– ), retired CEO, MillerCoors LLC, Golden, CO; formerly with Frito-Lay

Kathryn B. McQuade (2012– ), retired EVP and CFO, Canadian Pacific Railway Limited; formerly with Norfolk Southern Corporation

George Muñoz (2004– ), principal, Muñoz Investment Banking Group, LLC, Washington, DC; Partner, Tobin & Muñoz, Chicago, IL; formerly Overseas Private Investment Corporation and assistant secretary of the United States Treasury Department

Nabil Y. Sakkab (2008– ), retired Senior Vice President, corporate research and development, Procter & Gamble, Cincinnati, OH

Headquarters

Prior to being based in Virginia, Philip Morris had its headquarters in Midtown Manhattan, New York City. In 2003, Philip Morris announced that it would move its headquarters to Virginia. The company said that it planned to keep around 750 employees in its former headquarters. Brendan McCormick, a spokesperson for Philip Morris, said that the company estimated that the move would save the company over $60 million each year. The company now has its head offices in an unincorporated area of Henrico County, Virginia, near Richmond. In addition, the company has a 450,000-square-foot, $350 million Center for Research and Technology located in downtown Richmond at the Virginia BioTechnology Research Park that employs approximately 600 scientists, engineers and support staff.

Diversification

Altria, like other tobacco companies, has invested in science and medical companies which develop and produce medical products for conditions caused or aggravated by smoking. As of 2024, Altria's three medical subsidiaries included the following: Cronos group (maker of recreational cannabis), Lexaria Bioscience (Developer of proprietary drug delivery technology, DehydraTECH, to improve active pharmaceutical ingredients entrance into the bloodstream) and Micreos (biotech company focused on discovering and developing recombinant proteins for chronic dermatology and oncology conditions).

It has also designed and marketed electronic cigarettes. Altria launched the MarkTen and Green Smoke brands. Both of these were discontinued in December 2018. The company returned to this market through the acquisition of NJOY.

Political influence

According to the Center for Public Integrity, Altria spent around $101 million on lobbying the United States government between 1998 and 2004, the second-highest such figure for any organization in the nation.

Altria also funded The Advancement of Sound Science Coalition which lobbied against the scientific consensus on anthropogenic climate change.

Daniel Smith, representing Altria, sits on the Private Enterprise Board of the American Legislative Exchange Council.

In 2025, Altria was one of the donors funding the White House's East Wing demolition, and planned building of a ballroom.

Controversies

In August 2006, the Altria group was found guilty of civil fraud and racketeering. The lawsuit claimed that Altria's marketing of "light" and "low tar" cigarettes constituted fraudulent misrepresentations under the Maine Unfair Trade Practices Act (MUTPA) because it deceived smokers into thinking the products are safer than regular cigarettes.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 99 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

99 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
March 1, 2007 MDLZ S 1,449,240 $32.08 $46,491,619 275,000,000 Direct -0.52% Disposed 101.2% (price as of 2026-08-20)

Showing latest 100 of 317 transactions

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Feb. 16, 2007 MDLZ Employee Stock Option (right to buy) Common Stock (890) $31.00 June 12, 2011 890 Disposed
Feb. 14, 2007 MDLZ Employee Stock Option (right to buy) Common Stock (1,590) $31.00 June 12, 2011 1,590 Disposed
Feb. 13, 2007 MDLZ Employee Stock Option (right to buy) Common Stock (970) $31.00 June 12, 2011 970 Disposed
Feb. 12, 2007 MDLZ Employee Stock option (right to buy) Common Stock (3,450) $31.00 June 12, 2011 3,450 Disposed
Feb. 8, 2007 MDLZ Employee Stock option (right to buy) Common Stock (300) $31.00 June 12, 2011 300 Disposed
Feb. 7, 2007 MDLZ Employee Stock option (right to buy) Common Stock (390) $31.00 June 12, 2011 390 Disposed
Feb. 6, 2007 MDLZ Employee Stock option (right to buy) Common Stock (860) $31.00 June 12, 2011 860 Disposed
Feb. 1, 2007 MDLZ Employee Stock option (right to buy) Common Stock (2,080) $31.00 June 12, 2011 2,080 Disposed
Jan. 31, 2007 MDLZ Employee Stock option (right to buy) Common Stock (1,370) $31.00 June 12, 2011 1,370 Disposed
Jan. 30, 2007 MDLZ Employee Stock option (right to buy) Common Stock (2,860) $31.00 June 12, 2011 2,860 Disposed
Jan. 29, 2007 MDLZ Employee Stock option (right to buy) Common Stock (810) $31.00 June 12, 2011 810 Disposed
Jan. 25, 2007 MDLZ Employee Stock option (right to buy) Common Stock (650) $31.00 June 12, 2011 650 Disposed
Jan. 23, 2007 MDLZ Employee Stock option (right to buy) Common Stock (1,010) $31.00 June 12, 2011 1,010 Disposed
Jan. 22, 2007 MDLZ Employee Stock option (right to buy) Common Stock (520) $31.00 June 12, 2011 520 Disposed
Jan. 19, 2007 MDLZ Employee Stock option (right to buy) Common Stock (100) $31.00 June 12, 2011 100 Disposed
Jan. 17, 2007 MDLZ Employee Stock option (right to buy) Common Stock (1,010) $31.00 June 12, 2011 1,010 Disposed
Jan. 12, 2007 MDLZ Employee Stock option (right to buy) Common Stock (5,120) $31.00 June 12, 2011 5,120 Disposed
Jan. 11, 2007 MDLZ Employee Stock option (right to buy) Common Stock (2,950) $31.00 June 12, 2011 2,950 Disposed
Jan. 9, 2007 MDLZ Employee Stock option (right to buy) Common Stock (540) $31.00 June 12, 2011 540 Disposed
Jan. 8, 2007 MDLZ Employee Stock option (right to buy) Common Stock (1,780) $31.00 June 12, 2011 1,780 Disposed
Jan. 5, 2007 MDLZ Employee Stock option (right to buy) Common Stock (100) $31.00 June 12, 2011 100 Disposed
Jan. 4, 2007 MDLZ Employee Stock option (right to buy) Common Stock (100) $31.00 June 12, 2011 100 Disposed
Jan. 3, 2007 MDLZ Employee Stock option (right to buy) Common Stock (100) $31.00 June 12, 2011 100 Disposed
Dec. 28, 2006 MDLZ Employee Stock Option (right to buy) Common Stock (360) $31.00 June 12, 2011 360 Disposed
Dec. 27, 2006 MDLZ Employee Stock option (right to buy) Common Stock (740) $31.00 June 12, 2011 740 Disposed
Dec. 21, 2006 MDLZ Employee Stock option (right to buy) Common Stock (300) $31.00 June 12, 2011 300 Disposed
Dec. 20, 2006 MDLZ Employee Stock option (right to buy) Common Stock (1,300) $31.00 June 12, 2011 1,300 Disposed
Dec. 19, 2006 MDLZ Employee stock option (right to buy) Common Stock (960) $31.00 June 12, 2011 960 Disposed
Dec. 18, 2006 MDLZ Employee stock option (right to buy) Common Stock (1,060) $31.00 June 12, 2011 1,060 Disposed
Dec. 15, 2006 MDLZ Employee stock option (right to buy) Common Stock (590) $31.00 June 12, 2011 590 Disposed
Dec. 14, 2006 MDLZ Employee stock option (right to buy) Common Stock (260) $31.00 June 12, 2011 260 Disposed
Dec. 13, 2006 MDLZ Employee stock option (right to buy) Common Stpck (960) $31.00 June 12, 2011 960 Disposed
Dec. 12, 2006 MDLZ Employee stock option (right to buy) Common Stpck (100) $31.00 June 12, 2011 100 Disposed
Dec. 8, 2006 MDLZ Employee stock option (right to buy) Common Stock (200) $31.00 June 12, 2011 200 Disposed
Dec. 7, 2006 MDLZ Employee stock option (right to buy) Common Stock (340) $31.00 June 12, 2011 340 Disposed
Dec. 4, 2006 MDLZ Employee stock option (right to buy) Common Stock (970) $31.00 June 12, 2011 970 Disposed
Dec. 1, 2006 MDLZ Employee stock option (right to buy) Common Stock (200) $31.00 June 12, 2011 200 Disposed
Nov. 30, 2006 MDLZ Employee stock option (right to buy) Common Stock (380) $31.00 June 12, 2011 380 Disposed
Nov. 27, 2006 MDLZ Employee stock option (right to buy) Common Stock (500) $31.00 June 12, 2011 500 Disposed
Nov. 24, 2006 MDLZ Employee stock option (right to buy) Common Stock (1,060) $31.00 June 12, 2011 1,060 Disposed
Nov. 20, 2006 MDLZ Employee stock option (right to buy) Common Stock (250) $31.00 June 12, 2011 250 Disposed
Nov. 17, 2006 MDLZ Employee stock option (right to buy) Common Stock (810) $31.00 June 12, 2011 810 Disposed
Nov. 7, 2006 MDLZ Employee stock option (right to buy) Common Stock (930) $31.00 June 12, 2011 930 Disposed
Oct. 30, 2006 MDLZ Employee stock option (right to buy) Common Stock (660) $31.00 June 12, 2011 660 Disposed
Oct. 27, 2006 MDLZ Employee stock option (right to buy) Common Stock (520) $31.00 June 12, 2011 520 Disposed
Oct. 23, 2006 MDLZ Employee stock option (right to buy) Common Stock (1,040) $31.00 June 12, 2011 1,040 Disposed
Oct. 17, 2006 MDLZ Employee stock option (right to buy) Common Stock (1,600) $31.00 June 12, 2011 1,600 Disposed
Oct. 16, 2006 MDLZ Employee stock option (right to buy) Common Stock (1,330) $31.00 June 12, 2011 1,330 Disposed
Oct. 12, 2006 MDLZ Employee stock option (right to buy) Common Stock (920) $31.00 June 12, 2011 920 Disposed
Oct. 11, 2006 MDLZ Employee stock option (right to buy) Common Stock (1,440) $31.00 June 12, 2011 1,440 Disposed
Oct. 5, 2006 MDLZ Employee stock option (right to buy) Common Stock (490) $31.00 June 12, 2011 490 Disposed
Sept. 29, 2006 MDLZ Employee stock option (right to buy) Common Stock (200) $31.00 June 12, 2011 200 Disposed
Sept. 27, 2006 MDLZ Employee stock option (right to buy) Common Stock (1,060) $31.00 June 12, 2011 1,060 Disposed
Sept. 26, 2006 MDLZ Employee stock option (right to buy) Common Stock (6,370) $31.00 June 12, 2011 6,370 Disposed
Sept. 25, 2006 MDLZ Employee stock option (right to buy) Common Stock (1,350) $31.00 June 12, 2011 1,350 Disposed
Sept. 21, 2006 MDLZ Employee stock option (right to buy) Common Stock (250) $31.00 June 12, 2011 250 Disposed
Sept. 15, 2006 MDLZ Employee stock option (right to buy) Common Stock (100) $31.00 June 12, 2011 100 Disposed
Sept. 12, 2006 MDLZ Employee stock option (right to buy) Common Stock (270) $31.00 June 12, 2011 270 Disposed
Sept. 1, 2006 MDLZ Employee stock option (right to buy) Common Stock (330) $31.00 June 12, 2011 330 Disposed
Aug. 31, 2006 MDLZ Employee stock option (right to buy) Common Stock (1,370) $31.00 June 12, 2011 1,370 Disposed
Aug. 30, 2006 MDLZ Employee stock option (right to buy) Common Stock (3,330) $31.00 June 12, 2011 3,330 Disposed
Aug. 28, 2006 MDLZ Employee stock option (right to buy) Common Stock (100) $31.00 June 12, 2011 100 Disposed
Aug. 14, 2006 MDLZ Employee stock option (right to buy) Common Stock (680) $31.00 June 12, 2011 680 Disposed
Aug. 8, 2006 MDLZ Employee stock option (right to buy) Common Stock (250) $31.00 June 12, 2011 250 Disposed
Aug. 4, 2006 MDLZ Employee stock option (right to buy) Common Stock (330) $31.00 June 12, 2011 330 Disposed
July 26, 2006 MDLZ Employee stock option (right to buy) Common Stock (260) $31.00 June 12, 2011 260 Disposed
July 25, 2006 MDLZ Employee stock option (right to buy) Common Stock (540) $31.00 June 12, 2011 540 Disposed
June 1, 2006 MDLZ Employee stock option (right to buy) Common Stock (250) $31.00 June 12, 2011 250 Disposed
May 30, 2006 MDLZ Employee stock option (right to buy) Common Stock (540) $31.00 June 12, 2011 540 Disposed
May 26, 2006 MDLZ Employee stock option (right to buy) Common Stock (890) $31.00 June 12, 2011 890 Disposed
May 24, 2006 MDLZ Employee stock option (right to buy) Common Stock (1,525) $31.00 June 12, 2011 1,525 Disposed
May 19, 2006 MDLZ Employee stock option (right to buy) Common Stock (280) $31.00 June 12, 2011 280 Disposed
May 2, 2006 MDLZ Employee stock option (right to buy) Class A Common Stock (1,850) $31.00 June 12, 2011 1,850 Disposed
July 6, 2005 MDLZ Employee stock option (right to buy) Class A Common (100) $31.00 June 12, 2011 100 Disposed
June 30, 2005 MDLZ Employee stock option (right to buy) Class A Common (620) $31.00 June 12, 2011 620 Disposed
June 23, 2005 MDLZ Employee stock option (right to buy) Class A Common (1,880) $31.00 June 12, 2011 1,880 Disposed
June 22, 2005 MDLZ Employee stock option (right to buy) Class A Common (1,180) $31.00 June 12, 2011 1,180 Disposed
June 20, 2005 MDLZ Employee stock option (right to buy) Class A Common (810) $31.00 June 12, 2011 810 Disposed
June 10, 2005 MDLZ Employee stock option (right to buy) Class A Common (190) $31.00 June 12, 2011 190 Disposed
May 31, 2005 MDLZ Employee stock option (right to buy) Class A Common (5,020) $31.00 June 12, 2011 5,020 Disposed
May 26, 2005 MDLZ Employee stock option (right to buy) Class A Common (740) $31.00 June 12, 2011 740 Disposed
May 25, 2005 MDLZ Employee stock option (right to buy) Class A Common (410) $31.00 June 12, 2011 410 Disposed
May 19, 2005 MDLZ Employee stock option (right to buy) Class A Common (880) $31.00 June 12, 2011 880 Disposed
May 16, 2005 MDLZ Employee stock option (right to buy) Class A Common (820) $31.00 June 12, 2011 820 Disposed
May 9, 2005 MDLZ Employee stock option (right to buy) Class A Common (100) $31.00 June 12, 2011 100 Disposed
May 2, 2005 MDLZ Employee stock option (right to buy) Class A Common (280) $31.00 June 12, 2011 280 Disposed
April 29, 2005 MDLZ Employee stock option (right to buy) Class A Common (970) $31.00 June 12, 2011 970 Disposed
March 14, 2005 MDLZ Employee stock option (right to buy) Class A Common (1,280) $31.00 June 12, 2011 1,280 Disposed
March 11, 2005 MDLZ Employee stock option (right to buy) Class A Common (350) $31.00 June 12, 2011 350 Disposed
March 7, 2005 MDLZ Employee stock option (right to buy) Class A Common (100) $31.00 June 12, 2011 100 Disposed
Feb. 28, 2005 MDLZ Employee stock option (right to buy) Class A Common (390) $31.00 June 12, 2011 390 Disposed
Feb. 25, 2005 MDLZ Employee stock option (right to buy) Class A Common (2,910) $31.00 June 12, 2011 2,910 Disposed
Feb. 24, 2005 MDLZ Employee stock option (right to buy) Class A Common (200) $31.00 June 12, 2011 200 Disposed
Feb. 22, 2005 MDLZ Employee stock option (right to buy) Class A Common (1,430) $31.00 June 12, 2011 1,430 Disposed
Feb. 18, 2005 MDLZ Employee stock option (right to buy Class A Common (300) $31.00 June 12, 2011 300 Disposed
Feb. 9, 2005 MDLZ Empoyee stock option (right to buy) Class A Common (260) $31.00 June 12, 2011 260 Disposed
Feb. 8, 2005 MDLZ Employee stock option (right to buy) Class A Common (1,130) $31.00 June 12, 2011 1,130 Disposed
Feb. 2, 2005 MDLZ Employee stock option (right to buy) Class A Common (650) $31.00 June 12, 2011 650 Disposed
Jan. 24, 2005 MDLZ Employee stock option (right to buy) Class A Common (200) $31.00 June 12, 2011 200 Disposed
Jan. 19, 2005 MDLZ Employee stock option (right to buy) Class A Common (770) $31.00 June 12, 2011 770 Disposed

Showing latest 100 of 157 transactions

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
March 7, 2008 MO Common Stock 150 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

MO

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2019 $871,667 $2,200,099 $2,456,241 $104,052 $9,373,759
2014 $1,241,667 $5,250,206 $2,629,203 $249,914 $12,320,990
2011 $787,117 $1,650,208 $925,088 $150,208 $4,612,621

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.